- Home
- BFRG vs HOTH Comparison
BFRG vs HOTH Comparison
Compare BFRG & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFRG
- HOTH
- Stock Information
- Founded
- BFRG 2017
- HOTH 2017
- Country
- BFRG United States
- HOTH United States
- Employees
- BFRG N/A
- HOTH N/A
- Industry
- BFRG Retail: Computer Software & Peripheral Equipment
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- BFRG Technology
- HOTH Health Care
- Exchange
- BFRG Nasdaq
- HOTH Nasdaq
- Market Cap
- BFRG 16.4M
- HOTH 15.6M
- IPO Year
- BFRG 2023
- HOTH 2019
- Fundamental
- Price
- BFRG $1.14
- HOTH $1.33
- Analyst Decision
- BFRG
- HOTH Strong Buy
- Analyst Count
- BFRG 0
- HOTH 3
- Target Price
- BFRG N/A
- HOTH $4.00
- AVG Volume (30 Days)
- BFRG 92.3K
- HOTH 1.4M
- Earning Date
- BFRG 08-13-2025
- HOTH 08-12-2025
- Dividend Yield
- BFRG N/A
- HOTH N/A
- EPS Growth
- BFRG N/A
- HOTH N/A
- EPS
- BFRG N/A
- HOTH N/A
- Revenue
- BFRG $33,257.00
- HOTH N/A
- Revenue This Year
- BFRG N/A
- HOTH N/A
- Revenue Next Year
- BFRG N/A
- HOTH N/A
- P/E Ratio
- BFRG N/A
- HOTH N/A
- Revenue Growth
- BFRG N/A
- HOTH N/A
- 52 Week Low
- BFRG $1.09
- HOTH $0.65
- 52 Week High
- BFRG $4.84
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- BFRG 33.22
- HOTH 55.66
- Support Level
- BFRG $1.18
- HOTH $1.21
- Resistance Level
- BFRG $1.27
- HOTH $1.38
- Average True Range (ATR)
- BFRG 0.06
- HOTH 0.07
- MACD
- BFRG -0.00
- HOTH 0.01
- Stochastic Oscillator
- BFRG 21.01
- HOTH 63.67
About BFRG Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).